Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors

The kinetics of 18 amino acids, ammonia (NH3) and urea (UREA) in 18 liver cell bioreactor runs were analyzed and simulated by a two-compartment model consisting of a system of 42 differential equations. The model parameters, most of them representing enzymatic activities, were identified and their values discussed with respect to the different liver cell bioreactor performance levels. The nitrogen balance based model was used as a tool to quantify the variability of runs and to describe different kinetic patterns of the amino acid metabolism, in particular with respect to glutamate (GLU) and aspartate (ASP)

In Vitro Model for Hepatotoxicity Studies Based on Primary Human Hepatocyte Cultivation in a Perfused 3D Bioreactor System

Accurate prediction of the potential hepatotoxic nature of new pharmaceuticals remains highly challenging. Therefore, novel in vitro models with improved external validity are needed to investigate hepatic metabolism and timely identify any toxicity of drugs in humans. In this study, we examined the effects of diclofenac, as a model substance with a known risk of hepatotoxicity in vivo, in a dynamic multi-compartment bioreactor using primary human liver cells. Biotransformation pathways of the drug and possible effects on metabolic activities, morphology and cell transcriptome were evaluated. Formation rates of diclofenac metabolites were relatively stable over the application period of seven days in bioreactors exposed to 300 µM diclofenac (300 µM bioreactors (300 µM BR)), while in bioreactors exposed to 1000 µM diclofenac (1000 µM BR) metabolite concentrations declined drastically. The biochemical data showed a significant decrease in lactate production and for the higher dose a significant increase in ammonia secretion, indicating a dose-dependent effect of diclofenac application. The microarray analyses performed revealed a stable hepatic phenotype of the cells over time and the observed transcriptional changes were in line with functional readouts of the system. In conclusion, the data highlight the suitability of the bioreactor technology for studying the hepatotoxicity of drugs in vitro

(13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.

We present the first validated metabolic network model for analysis of flux through key pathways of tumor intermediary metabolism, including glycolysis, the oxidative and non-oxidative arms of the pentose pyrophosphate shunt, the TCA cycle as well as its anaplerotic pathways, pyruvate-malate shuttling, glutaminolysis, and fatty acid biosynthesis and oxidation. The model that is called Bonded Cumomer Analysis for application to (13)C magnetic resonance spectroscopy ((13)C MRS) data and Fragmented Cumomer Analysis for mass spectrometric data is a refined and efficient form of isotopomer analysis that can readily be expanded to incorporate glycogen, phospholipid, and other pathways thereby encompassing all the key pathways of tumor intermediary metabolism. Validation was achieved by demonstrating agreement of experimental measurements of the metabolic rates of oxygen consumption, glucose consumption, lactate production, and glutamate pool size with independent measurements of these parameters in cultured human DB-1 melanoma cells. These cumomer models have been applied to studies of DB-1 melanoma and DLCL2 human diffuse large B-cell lymphoma cells in culture and as xenografts in nude mice at 9.4 T. The latter studies demonstrate the potential translation of these methods to in situ studies of human tumor metabolism by MRS with stable (13)C isotopically labeled substrates on instruments operating at high magnetic fields (≥7 T). The melanoma studies indicate that this tumor line obtains 51% of its ATP by mitochondrial metabolism and 49% by glycolytic metabolism under both euglycemic (5 mM glucose) and hyperglycemic conditions (26 mM glucose). While a high level of glutamine uptake is detected corresponding to ~50% of TCA cycle flux under hyperglycemic conditions, and ~100% of TCA cycle flux under euglycemic conditions, glutaminolysis flux and its contributions to ATP synthesis were very small. Studies of human lymphoma cells demonstrated that inhibition of mammalian target of rapamycin (mTOR) signaling produced changes in flux through the glycolytic, pentose shunt, and TCA cycle pathways that were evident within 8 h of treatment and increased at 24 and 48 h. Lactate was demonstrated to be a suitable biomarker of mTOR inhibition that could readily be monitored by (1)H MRS and perhaps also by FDG-PET and hyperpolarized (13)C MRS methods

In silico Derivation of a Reduced Kinetic Model for Stationary or Oscillating Glycolysis in Escherichia coli Bacterium

Modelling bacteria glycolysis is a classical subject but still of high interest. Glycolysis, together with the phosphotransferase (PTS)-system for glucose transport into the cell, the pentose-phosphate pathway (PPP), and tricarboxylic acid cycle (TCA) characterize the central carbon metabolism. Such a model usually serves as the foundation for developing modular simulation platforms used for consistent analysis of the control / regulation of target metabolite synthesis. The present study is focused on analyzing the advantage and limitations of using a simplified but versatile ‘core’ model of mTRM) of glycolysis when incomplete experimental information is available. Exemplification is made for a reduced glycolysis model from literature for Escherichia coli cells, by performing a few modifications (17 identifiable parameters) to increase its agreement with simulated data generated by using an extended model (127 parameters) over a large operating domain of an experimental bioreactor. With the expense of ca. 8–13 % increase in the relative model error vs. extended simulation models, derivation of reduced kinetic structures to describe some parts of the core metabolism is worth the associated identification effort, due to the considerable reduction in model parameterization (e.g. 17 parameters in mTRM vs. 127 in the extendedChassM model of Chassagnole et al.), while preserving a fair adequacy over a wide experimental domain generated in-silico by using the valuable extended ChassM. The reduced model flexibility is tested by reproducing stationary or oscillatory glycolysis conditions. The reduced mTRM model includes enough information to reproduce not only the cell energy-related potential through the total A(MDT)P level, but also the role played by ATP/ADP ratio as a glycolysis driving force. The model can also reproduce the oscillatory behaviour occurrence conditions, as well as situations when homeostatic conditions are not fulfilled

Bioreactor technologies to support liver function in vitro

Liver is a central nexus integrating metabolic and immunologic homeostasis in the human body, and the direct or indirect target of most molecular therapeutics. A wide spectrum of therapeutic and technological needs drives efforts to capture liver physiology and pathophysiology in vitro, ranging from prediction of metabolism and toxicity of small molecule drugs, to understanding off-target effects of proteins, nucleic acid therapies, and targeted therapeutics, to serving as disease models for drug development. Here we provide perspective on the evolving landscape of bioreactor-based models to meet old and new challenges in drug discovery and development, emphasizing design challenges in maintaining long-term liver-specific function and how emerging technologies in biomaterials and microdevices are providing new experimental models.National Institutes of Health (U.S.) (R01 EB010246)National Institutes of Health (U.S.) (P50-GM068762-08)National Institutes of Health (U.S.) (R01-ES015241)National Institutes of Health (U.S.) (P30-ES002109)5UH2TR000496-02National Science Foundation (U.S.). Emergent Behaviors of Integrated Cellular Systems (CBET-0939511)United States. Defense Advanced Research Projects Agency. Microphysiological Systems Program (W911NF-12-2-0039

Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model

Cell cultured-based influenza virus production is a viable option for vaccine manufacturing. In order to achieve a high concentration of viable cells, is requirement to have not only optimal process conditions, but also an active metabolism capable of intracellular synthesis of viral components. Experimental metabolic data collected in such processes are complex and difficult to interpret, for which mathematical models are an appropriate way to simulate and analyze the complex and dynamic interaction between the virus and its host cell. A dynamic model with 35 states was developed in this study to describe growth, metabolism, and influenza A virus production in shake flask cultivations of suspension Madin-Darby Canine Kidney (MDCK) cells. It considers cell growth (concentration of viable cells, mean cell diameters, volume of viable cells), concentrations of key metabolites both at the intracellular and extracellular level and virus titers. Using one set of parameters, the model accurately simulates the dynamics of mock-infected cells and correctly predicts the overall dynamics of virus-infected cells for up to 60 h post infection (hpi). The model clearly suggests that most changes observed after infection are related to cessation of cell growth and the subsequent transition to apoptosis and cell death. However, predictions do not cover late phases of infection, particularly for the extracellular concentrations of glutamate and ammonium after about 12 hpi. Results obtained from additional in silico studies performed indicated that amino acid degradation by extracellular enzymes resulting from cell lysis during late infection stages may contribute to this observed discrepancy

Characterisation of encapsulated embryonic stem cells using silac-based proteomics

The embryonic stem cells have two hallmarks characters, the ability to reproduce self-renewal and generate other cell lineages. Despite the excessive advance in stem cell research, their clinical applications delay owing lack of an optimal culture condition in vitro. Combining biometrical scaffold with stem cells provides a promising way to cellular delivery and tissue transplant. In vitro 3D culture offers both a model to understand self-renewal and stem cell behaviour in vivo as a route to industrial production. We have used a variety of analytical tools including proteomics and quantitative RT-PCR to compare 3D (both static & dynamic) with 2D cultures. We further show that 3D dynamic culture increases expression of the master gene regulators (Oct4, Nanog and Sox2). Consistent with this Rex1, an inner-cell mass (ICM) associated marker, is over-expressed in 3D dynamic culture whereas Fgf5, an epiblast transition marker is down-regulated. Using SILAC-based proteomics to compare 2D vs. 3D dynamic culture, we show that encapsulated stem cell are characterized by glycolytic pathways down-regulation and increased mitochondrial respiratory proteins. Additionally, ECM proteins expression (laminin, fibronectin, heparan sulfate (HS) proteoglycans, agrin, and nidogen-2) were up-regulated. Cells shortly after encapsulation in 3D constructs (both static &dynamic) showed high oxygen uptake rates compared to 2D culture. After 9 days of encapsulation glucose uptake increased in both static & dynamic 3D cultures and was combined with a pronounced increase in cell density and up-regulation of hypoxia induce-factors (HIf-1α and Hif-2α). This shift in metabolism toward anaerobic glycolysis is associated with high expression of hexokinas2 (Hk2) and increased lactate production. Despite extensive cell proliferation at day 18, where cell numbers reached up to 80k/ bead, cells in dynamic culture switched back from anaerobic to aerobic metabolism. This alteration in energy consumption was not associated with nutrient depletion since both glucose and glutamate were not depleted in the culture medium. By monitoring the oxygen consumption, hypoxia-induced factors expression as well as Oct4 levels at different time points, we demonstrate that the stem cells self-renewal status in 3D condition is regulated despite the metabolism transitions. We postulate that the 3D culture environment provides the niche required sensing and responding to external and internal stimuli different from recognised in vitro embryonic stem cell behaviour.Open Acces